Member Info for Florida

Steve - All you are saying is absolutely right but I need your opinion whether those automated trades I was referring to are responsible for the 16p noose.

If anyone else can come up with a better reason why we are stuck at 16p I would like to here.

Steve - That's great, they have just changed it. Four days ago Market Screener showed - YGEN/Ratings/Weaknesses - instead of "Based on current prices, the company has particularly high valuation levels." - it read, and I quote "The E/V value to sales is the highest in the world and should be gotten rid of". You will notice they even used the same term "gotten rid of" in one of the other weaknesses. if they wish to sue me, they are quite welcome. The good news is that the new figures have now been recognised which might give us a new broker rating. Obviously got it wrong on this point, can't trust anything anymore.

Having said that the old figures still apply, nothing new has been officially confirmed.and your £17m is an estimation, not a fact. Not trying to justify this error just that only my description is wrong based on the Market Screener description.

The new EV Values of 2020 - 5.60x and 2021 - 4.30x are projections and not facts.

I calculated this on Monday at which time the capitalisation was £89 million. Based on that calculation -

Market cap: £89m
Debt: £5m Plus
Cash: £3m Minus
= £91m
Divided by net sales - £3.4m
Enterprise Value to Sales - 26.7

Which is double the industry/sector average. These are the only factual figures. All else is theoretical without audited accounts. Of course we all know these are not the true present figures, we are just trying to establish what automated criterion is used and how it's established. An added thought, do we assume from this that having got wind of the new accounting figures are they expecting imminent news.
GLA

Steve - your numbers might be slightly askew, if I haven't misread you, we want that number to be as low as possible, under the average not higher. Apart from debt, we still have debt, right. Thermo Ficsher did right of the debt, however they also tied us into a nominal fee to be paid on all sales to a maximum total of £5m. A percentage of which may have already been paid, unfortunately we cannot determine what that nominal fee is and to what extent the sales have reached. So this would be calculated as debt £5m. All the other stuff is absolutely right, it is base on last years figures and that's the problem. We are still in the realm of non profit.

The Enterprise Value to sales for YGEN is appraximately 26. The Industry/Sector average Value is between 12 - 15. If you want some evidence go to Market Screener. I actually used there description of the value.

I know this is going to make a lot of you guys sit up and think. But lets get one thing clear, I'm heavily invested hear and that vested interest goes to all you guys as well. If one wins we all win, so don't think for a moment that I have any other reason other than to enrich all shareholders knowledge in order to secure in their own minds that this is the best company on AIM. My hope is that they hold until we reach "Breakeven" at which point the price will explode.

Enterprise Value to sales - Google it.

Yes, good posts Flipper, your back in my good books. Thank god someone has an inclination of whats going on here. This share will never breach 16.0p (imho) for any length of time until we are through "breakeven". I tried to point this out a few days ago. Please bare in mind this is only my theory and would like views to the contrary. YGEN's trading range is 30,000 and many of those trades within that range are what you might call institutional trades like Unit trusts, Hedge funds and the like, mostly, if not all are automated trades. The decision to buy or sell is calculated by algorithmic system analysis and
the criterion to establish the value of a company and whether to buy or sell is determined by the P/E ratio and the E/V to sales ratio. A specific calculation is derived for each, just google P/E or E/V ratio and you can work it out for yourself. Also, there is a P/E and E/V value to each Industry/Sector and the average is taken from each company within that industry/sector to determine the P/E or E/V. The ultimate analysis decision whether to use the P/E value, the E/V value or both is governed by "Breakeven". If we are not yet into profit and are below "Breakeven" analysis ignores the P/E value completely, reverting solely to E/V to sales. The problem for us is that the E/V for YGEN is the highest in the world, making us virtually untouchable at any price over the broker rating of 16.0p. That's why you always see a flood of sells between 15.5p and 16.0p.

The saving grace to this is volume and momentum. If shares become scarce and more private investors buy in, the impact of auto selling is less and the price is driven up, but as soon as momentum drops, the price goes back to 16.00p. To fully break out of this cycle we desperately need to surpass "Breakeven".

I deliberately held back from posting this because I thought it might deter potential investors, but the last few days have shown that volumes are up and pressure is building. With an EBITDA of only £0.3m ("Breakeven") the recent acquisition (£500,000 py additional income) and this COVID 19 collaboration, I believe, will push us through to profit much sooner than expected. Last year final results were given on the 10th July with end of year 31st March accounting period, 3.5 months to get the accounts together is a heck of a long time, so I think it could be sooner. Not to mention the possible unaudited announcement of "Beakeven" in the April trading update. GLA

Too early to say but we may have just broke through the P/E and E/V to sales ratio's restriction. We will know for sure if the FTSE 100 reverses this afternoon.

There is an artical on the Genomeweb front page that for some reason I cannot open , if anyone wants to take a look.

Interesting post from ADVFN -
"Just on the news 15 minute home test for covid 19 available within days"

Moveonup - Too many negative waves man. I strongly believe many have underestimated Petro Chinas ambitions into Mongolia. A joint effort alongside MATD could develop into quite a number of future wells. A 50/50 relationship would resolve the financing issue, provide a sustained rig availability, a convenient route to market for anything pumped up before the refinery is completed and all Your fears would evaporate in one fail swoop.

I believe a relationship of this kind would require the cooperation of the Mongolian Government and would take time to organise/negotiate and approve, hence, no news on financing, no news on permits and no news on rigs. So my message to all is don't panic just listen to the poetic tones of the cool calm and collected Hongs Kong and watch the price double upon the announcement.

Good to see the MM's find it necessary to stem the flow of interest. We should welcome our newly found MM appointed guests with open arms and advise on better ways to research. All legitimate LTH's know there are no negatives with this company. The new Illumina platform will undoubtedly transform the sales of the IONA test throughout Europe and the States with other products already showing in excess of a 200% increase. Just a matter of waiting for pay day.

As far as I am aware the IONA test has no competition from anyone, anywhere, its 99.9% accurate. No one else comes anywhere near.

I'm not so bold as to use the word ridiculous but an inference that someone is stupid because he estimates the company's value at 50p should be directed towards Adam Renaulds. It was he who stated "if YGEN was floated on the NASDAQ today it would be valued at £380m". I won't do the maths for you flipper, I'm sure you can just about multiply x 4.

Must admit can't make head to tail of flippers recent posts. Apart from the fact that the Eulicigene purchase did not devalue the company so why mention 110m shares? The accusation of a turn cote de-ramper may be true after all.

We have been given no indication of what the modest sales commission is on the TF deal. The word "modest" is neither clear or exact so we cannot estimate when the £6.5m will be reached. However, the rapid expansion and sales multiples should have an effect and should reduce that expected time. Of course we should recognise that this deal with TF was agreed before the Eulicigene takeover. At that time we only had NIPT to sell, So does the so called modest commission only apply to NIPT or does it include 30 of Eulicigenes products. The latter would infer a speedier climb to the £6.5m still owed to TF. To carry along side this the research and development figure of £4.5m was an imposed figure, it was said at the time, to speed up the adoption/integration of the Illumina Platform. I'm sure we can all agree a research and Development figure of £4.5 million is substantial for a company of this size, more so, a company earning no profit. So does this figure diminish when the Illumina Platform is complete?. If so, that reduction should contribute to/ bring us forward nearer to break even.

The recent trading data has shown without doubt that shares are scarce. The pressure this brings to bare increases the opportunity to raise the share price. All those considering selling should think about the lucrative position we find ourselves in. Any announcement no matter how trivial has an effect in these circumstances, more so, Twix's belief in contract wins.

I cannot say I have the gloomy outlook that flipper portrays. The next 7 months should imv be the healthiest in the companies history.

None of us should forget the days of Vialogy when Twix played what could be deemed as the saving grace to many investors who could have lost far more. He screamed from the rafters for months if not years that something was wrong and no one listened, including me. So we must not judge on our predetermined view of someone based on a few remarks that we don't like. The proper constructive attitude should be to embrace what is said and question at all times what is presented to us. Twix plays a healthy critical role in deducting the true accountability of the company we invest in and we should not trivialise or ignore anything that is said.

Twix - your emphasis on the disclosure of contract wins is flawed to some extent in the fact that the "Land grab" took place with the purchase of Eucligene. Instead of venturing out targeting individual clients, Euligene presented us with ready made clients with the door already open. So in effect, new client contracts had already been established. It was then just a matter of selling additional products the to the already affiliated. The land grab to that effect was already fulfilled.

Good post Truro.

Mike Buck has made clear (imv) his financial route into the next development phase is through the Mongolian Banks. Having proclaimed this intention he would look rather shifty if he then turned that proclamation on it's head and opted for a Placing. Apparently, he's not the type to squander his reputation flippantly, and certainly would not make such a statement with the likelihood of an unsuccessful outcome. Much of business lending by Banks is based upon due-diligence, speculation, character of the borrower, and if any, the percentage asset involved. Petro Matad has all these characteristics and the added advantage of the borrowing itself implementing it's own security in that 25mbo becomes accessible as soon or thereafter the borrowing date. I think it goes without saying, in the process of acquiring Bank funding, our Chair Woman will have all the necessary contacts/experience and would be pivotal in those discussions. A successful outcome from talks with the Banks could be within the next few weeks (his words not mine).

I can't really see whats negative. we have a conservative estimate of 25 million barrels of oil in the hole (MB's words not mine), and as Captain Stanley said a CPR on the horizon that should substantiate even more. Whats not to like.

Mike Buck stated that the recent successful free flowing DST2 result is unusual for this particular area, which begs the question what was he realistically expecting to find?. Going by his hint in the recent podcast interview, preparations must have already been at hand in some way to tackle the 70 metre DST1 zone.

He said the 70 metre column height was hit as expected and they were already set and ready to Frack. Their attention was then drawn to the second test (DST2) because it required no frack stimulation. Reading from this they could already be in the process of fracking DST1. I can only conclude from "and we were already set up to do that" that fracking has already started. it's difficult to assume what is actually included in the overall resource estimates but it seems on the face of it the 70 metre zone is not assessed as a find, as yet, and may add to the overall resource assessment if fracking is successful.